Biotech Values

[linhdtu]

My logic tells me that if SNY is a rational actor( and there is nothing to make me believe it is not one) then it would not push the AG too hard nor price it at a great discount to the branded version.

Hence eventhough mnta pay off from sandoz has reverted to a royalty rate, unless there is a deep discount , the watermark will be reached in a quarter sales or so and the 45% profit will be back.